LEANDRA BROWN: Open Payments
NPI 1801570577 · DECATUR, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$954 in 41 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $649 · 2025 $954
Food & beverage: $859Education: $95
| Company | Payments | Amount |
|---|---|---|
| BeOne Medicines USA, Inc. | 7 | $122 |
| Merck Sharp & Dohme LLC | 5 | $119 |
| Daiichi Sankyo Inc. | 2 | $119 |
| Janssen Biotech, Inc. | 3 | $74 |
| AstraZeneca Pharmaceuticals LP | 3 | $68 |
| ABBVIE INC. | 3 | $68 |
| Lilly USA, LLC | 3 | $60 |
| E.R. Squibb & Sons, L.L.C. | 3 | $49 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $47 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $36 |
Products named: KEYTRUDA, Enhertu, BRUKINSA, VERZENIO, TEVIMBRA, OPDIVO, FRUZAQLA, IMFINZI.
Industry payments across AL — which companies pay providers there.
